medline.ch Onkologie Urologische Tumoren

	First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma. Oncol Res Valdés A, González-Montero J, Rojas C, Burotto M. PMID: 42500582 [PubMed - indexed for MEDLINE]
	Immunohistochemical Expression of Novel Therapeutic Targets in Squamous Cell Carcinoma of the Bladder. Oncol Res Frey LJ, Lache N, Fischer ND, Rölz N, Frey L, Haack M, Duwe G, Porubsky S, Haferkamp A, Wagner DC, Brandt MP. PMID: 42500580 [PubMed - indexed for MEDLINE]
	Integrative genomic profiling identifies MLPH as a candidate gene in prostate cancer. Front Med (Lausanne) Wang R, Wang J, Zhao Z, Hu X. PMID: 42500538 [PubMed]
	Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA-MIBC Study. Int J Urol Kikuchi E, Tokumaru J, Kawai D, Ide R, Komazaki H, Kitagawa H, Inokuchi J. PMID: 42499313 [PubMed - indexed for MEDLINE]
	Short-term clinical outcomes of cytoreductive radical prostatectomy combined with abiraterone-based androgen deprivation therapy in oligometastatic prostate cancer. Medicine (Baltimore) Li B, Qin Q, Liao J, Li L, Wang X, Hao P, Zhang A, Zhang G, Huang C. PMID: 42499100 [PubMed - indexed for MEDLINE]
	Identification of immune-related prognostic genes and construction of a risk model for Wilms tumor: A retrospective bioinformatics study. Medicine (Baltimore) Chen J, Yang G, Zhu Z, Liao J, Gu H. PMID: 42499033 [PubMed - indexed for MEDLINE]
	Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making. Eur Urol Mjaess G, Nicolazzini M, Amparore D, Bex A, Campi R, Cei F, Noyes SL, Re C, Rosiello G, Stewart GD, Volpe A, Palumbo C, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PMID: 42498608 [PubMed - as supplied by publisher]
	Ideal candidates for bladder preservation in muscle-invasive bladder cancer. Urol Oncol Oberoi JK, Ballas LK, Tyson M, Singh P. PMID: 42498593 [PubMed - as supplied by publisher]
	A spotlight on PTEN alterations in prostate cancer: a narrative review. Crit Rev Oncol Hematol Alaimo D, Di Costanzo F, Oltrecolli M, Oing C, Castro E, Rescigno P. PMID: 42497972 [PubMed - as supplied by publisher]
	Identification and validation of TP53/p53 status as a prognostic marker in penile squamous cell carcinoma: Evidence from a cohort study and meta-analysis. Urol Oncol Cai Z, Jin H, Guo Y, Chen D, Huang G, Jiang X, Liu J, Chen BN, Zhang X, Chen Z, Li Z. PMID: 42497775 [PubMed - as supplied by publisher]
	Not always a perfect match: discrepancies between PSMA PET/CT and MRI in prostate cancer diagnosis and staging. Abdom Radiol (NY) Lemos A, Woo S, Novaes A, Lucano M, Oliveira J, Torres C, Fukumori O, Gouvea G, Reis R, Vargas A, Muglia V. PMID: 42496916 [PubMed - as supplied by publisher]
	Does an emphasis on urinary continence compromise oncological outcomes after robot-assisted radical prostatectomy? World J Urol Matsumoto K, Fukumoto K, Yasumizu Y, Tanaka N, Takeda T, Asanuma H. PMID: 42496719 [PubMed - indexed for MEDLINE]
	Histotripsy for renal cell carcinoma: from animal studies to clinical application. Int J Hyperthermia Mutlu A, Falk KL, Kisting AL, Knavel Koepsel EM, Wagner MG, Hinshaw JL, Shapiro DD, Abel EJ, Swietlik JF, Laeseke PF, Ziemlewicz TJ, Lee FT, Golden ED. PMID: 42495873 [PubMed - indexed for MEDLINE]
	ACP3-targeted PET imaging agents based on small-molecule ligands for prostate cancer diagnostics and theranostics. Am J Nucl Med Mol Imaging Liang SH. PMID: 42495193 [PubMed]
	From Diagnosis to Disclosure: Navigating Genetic Counseling Dilemmas in BRCA2-Associated Prostate Cancer in the Middle East. Case Rep Genet van Wyk C, Abdulrahim R, Crous I, Al Saegh A, Al Balushi A, Al Muhairi B, Al Kiyumi S, Al Malki S, Al Harthy M. PMID: 42494986 [PubMed]
	Development and validation of a machine learning-based early warning model for bone metastasis in newly diagnosed prostate cancer. Front Oncol Wang L, He W, Zhao C, Lv Q, Qiu T, Zhai J, Mao K, Li D, Wen X. PMID: 42494601 [PubMed]
	Sequential gemcitabine-docetaxel in BCG-naÃ¯ve and BCG-failure non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Front Oncol Alhubaishy B, Beshawri I, Abulreish I, Alnajar O, Radhi H, Saleh A, Alwafi S, Halawani A. PMID: 42494591 [PubMed]
	Preliminary study on intravesical instillation of IL-12 mRNA lipid nanoparticles for the treatment of bladder cancer. Tumori Ouyang B, Wu Z, Li J, Zhu G, Shen Y, Lang M. PMID: 42494051 [PubMed - as supplied by publisher]
	Comment on: Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sharifan A. PMID: 42493582 [PubMed - as supplied by publisher]
	Electronic nose-based urinary volatilome profiling accurately discriminates bladder cancer from healthy controls: A prospective diagnostic study. Urol Oncol Filianoti A, Costantini M, Rosca V, Mastroianni R, Tuderti G, Ghezzo N, Simone G. PMID: 42493403 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 180292

Seite 1 von 9015

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung